Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
Identifieur interne : 003E56 ( Istex/Corpus ); précédent : 003E55; suivant : 003E57Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
Auteurs : Masato Kanazawa ; Takayoshi Shimohata ; Masahisa Sato ; Osamu Onodera ; Keiko Tanaka ; Masatoyo NishizawaSource :
- Movement Disorders [ 0885-3185 ] ; 2007-03-15.
Url:
DOI: 10.1002/mds.21367
Links to Exploration step
ISTEX:8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title><author><name sortKey="Kanazawa, Masato" sort="Kanazawa, Masato" uniqKey="Kanazawa M" first="Masato" last="Kanazawa">Masato Kanazawa</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Shimohata, Takayoshi" sort="Shimohata, Takayoshi" uniqKey="Shimohata T" first="Takayoshi" last="Shimohata">Takayoshi Shimohata</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Sato, Masahisa" sort="Sato, Masahisa" uniqKey="Sato M" first="Masahisa" last="Sato">Masahisa Sato</name><affiliation><mods:affiliation>Department of Neurology, Saiseikai Niigata Second Hospital, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Onodera, Osamu" sort="Onodera, Osamu" uniqKey="Onodera O" first="Osamu" last="Onodera">Osamu Onodera</name><affiliation><mods:affiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/mds.21367</idno><idno type="url">https://api.istex.fr/document/8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003E56</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title><author><name sortKey="Kanazawa, Masato" sort="Kanazawa, Masato" uniqKey="Kanazawa M" first="Masato" last="Kanazawa">Masato Kanazawa</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Shimohata, Takayoshi" sort="Shimohata, Takayoshi" uniqKey="Shimohata T" first="Takayoshi" last="Shimohata">Takayoshi Shimohata</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Sato, Masahisa" sort="Sato, Masahisa" uniqKey="Sato M" first="Masahisa" last="Sato">Masahisa Sato</name><affiliation><mods:affiliation>Department of Neurology, Saiseikai Niigata Second Hospital, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Onodera, Osamu" sort="Onodera, Osamu" uniqKey="Onodera O" first="Osamu" last="Onodera">Osamu Onodera</name><affiliation><mods:affiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Tanaka, Keiko" sort="Tanaka, Keiko" uniqKey="Tanaka K" first="Keiko" last="Tanaka">Keiko Tanaka</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author><author><name sortKey="Nishizawa, Masatoyo" sort="Nishizawa, Masatoyo" uniqKey="Nishizawa M" first="Masatoyo" last="Nishizawa">Masatoyo Nishizawa</name><affiliation><mods:affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-03-15">2007-03-15</date><biblScope unit="vol">22</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="597">597</biblScope><biblScope unit="page" to="598">598</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508</idno><idno type="DOI">10.1002/mds.21367</idno><idno type="ArticleID">MDS21367</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Masato Kanazawa MD</name><affiliations><json:string>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</json:string></affiliations></json:item><json:item><name>Takayoshi Shimohata MD, PhD</name><affiliations><json:string>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</json:string></affiliations></json:item><json:item><name>Masahisa Sato MD, PhD</name><affiliations><json:string>Department of Neurology, Saiseikai Niigata Second Hospital, Niigata, Japan</json:string></affiliations></json:item><json:item><name>Osamu Onodera MD, PhD</name><affiliations><json:string>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan</json:string></affiliations></json:item><json:item><name>Keiko Tanaka MD, PhD</name><affiliations><json:string>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</json:string></affiliations></json:item><json:item><name>Masatoyo Nishizawa MD, PhD</name><affiliations><json:string>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</json:string></affiliations></json:item></author><genre><json:string>Serial article</json:string></genre><host><volume>22</volume><pages><total>2</total><last>598</last><first>597</first></pages><issn><json:string>0885-3185</json:string></issn><issue>4</issue><subject><json:item><value>Letter to the Editors</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><language><json:string>eng</json:string></language><qualityIndicators><score>1.517</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>false</refBibsNative><abstractCharCount>0</abstractCharCount><pdfWordCount>1467</pdfWordCount><pdfCharCount>9372</pdfCharCount><pdfPageCount>2</pdfPageCount><abstractWordCount>0</abstractWordCount></qualityIndicators><title>Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title><publicationDate>2007</publicationDate><copyrightDate>2007</copyrightDate><doi><json:string>10.1002/mds.21367</json:string></doi><id>8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2007</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title><author><persName><forename type="first">Masato</forename><surname>Kanazawa</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</affiliation></author><author><persName><forename type="first">Takayoshi</forename><surname>Shimohata</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</affiliation></author><author><persName><forename type="first">Masahisa</forename><surname>Sato</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Neurology, Saiseikai Niigata Second Hospital, Niigata, Japan</affiliation></author><author><persName><forename type="first">Osamu</forename><surname>Onodera</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan</affiliation></author><author><persName><forename type="first">Keiko</forename><surname>Tanaka</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</affiliation></author><author><persName><forename type="first">Masatoyo</forename><surname>Nishizawa</surname><roleName type="degree">MD, PhD</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurology, Brain Research Institute, Niigata University, 1‐757 Asahimachi‐dori, Niigata, Niigata 951‐8585, Japan</p></note><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-03-15"></date><biblScope unit="vol">22</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="597">597</biblScope><biblScope unit="page" to="598">598</biblScope></imprint></monogr><idno type="istex">8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508</idno><idno type="DOI">10.1002/mds.21367</idno><idno type="ArticleID">MDS21367</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2007</date></creation><langUsage><language ident="en">en</language></langUsage><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Letter to the Editors</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2006-10-27">Received</change><change when="2006-11-17">Registration</change><change when="2007-03-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="40"><doi origin="wiley" registered="yes">10.1002/mds.v22:4</doi><numberingGroup><numbering type="journalVolume" number="22">22</numbering><numbering type="journalIssue">4</numbering></numberingGroup><coverDate startDate="2007-03-15">15 March 2007</coverDate></publicationMeta><publicationMeta level="unit" type="letter" position="350" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.21367</doi><idGroup><id type="unit" value="MDS21367"></id></idGroup><countGroup><count type="pageTotal" number="2"></count></countGroup><titleGroup><title type="articleCategory">Letter to the Editors</title><title type="tocHeading1">Letters to the Editors</title></titleGroup><copyright ownership="thirdParty">Copyright © 2007 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2006-10-27"></event><event type="manuscriptAccepted" date="2006-11-17"></event><event type="firstOnline" date="2007-01-31"></event><event type="publishedOnlineFinalForm" date="2007-03-27"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2007-01-31"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">597</numbering><numbering type="pageLast">598</numbering></numberingGroup><correspondenceTo>Department of Neurology, Brain Research Institute, Niigata University, 1‐757 Asahimachi‐dori, Niigata, Niigata 951‐8585, Japan</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS21367.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="9"></count><count type="wordTotal" number="954"></count></countGroup><titleGroup><title type="main" xml:lang="en">Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title><title type="short" xml:lang="en">Letters to the Editors</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Masato</givenNames><familyName>Kanazawa</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Takayoshi</givenNames><familyName>Shimohata</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Masahisa</givenNames><familyName>Sato</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Osamu</givenNames><familyName>Onodera</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af4"><personName><givenNames>Keiko</givenNames><familyName>Tanaka</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af4" corresponding="yes"><personName><givenNames>Masatoyo</givenNames><familyName>Nishizawa</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email normalForm="nishi@bri.niigata-u.ac.jp">nishi@bri.niigata‐u.ac.jp</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="JP" type="organization"><unparsedAffiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="JP" type="organization"><unparsedAffiliation>Department of Neurology, Saiseikai Niigata Second Hospital, Niigata, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="JP" type="organization"><unparsedAffiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af4" countryCode="JP" type="organization"><unparsedAffiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af5" countryCode="JP" type="organization"><unparsedAffiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af6" countryCode="JP" type="organization"><unparsedAffiliation>Department of Neurology, Saiseikai Niigata Second Hospital, Niigata, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af7" countryCode="JP" type="organization"><unparsedAffiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af8" countryCode="JP" type="organization"><unparsedAffiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</unparsedAffiliation></affiliation></affiliationGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Letters to the Editors</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases</title></titleInfo><name type="personal"><namePart type="given">Masato</namePart><namePart type="family">Kanazawa</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Takayoshi</namePart><namePart type="family">Shimohata</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Masahisa</namePart><namePart type="family">Sato</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, Saiseikai Niigata Second Hospital, Niigata, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Osamu</namePart><namePart type="family">Onodera</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Molecular Neuroscience, Brain Research Institute, Niigata University, Niigata, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Keiko</namePart><namePart type="family">Tanaka</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Masatoyo</namePart><namePart type="family">Nishizawa</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan</affiliation><description>Correspondence: Department of Neurology, Brain Research Institute, Niigata University, 1‐757 Asahimachi‐dori, Niigata, Niigata 951‐8585, Japan</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">letter</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2007-03-15</dateIssued><dateCaptured encoding="w3cdtf">2006-10-27</dateCaptured><dateValid encoding="w3cdtf">2006-11-17</dateValid><copyrightDate encoding="w3cdtf">2007</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">9</extent><extent unit="words">954</extent></physicalDescription><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Letter to the Editors</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>597</start><end>598</end><total>2</total></extent></part></relatedItem><identifier type="istex">8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508</identifier><identifier type="DOI">10.1002/mds.21367</identifier><identifier type="ArticleID">MDS21367</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2007 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003E56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:8A60E8BA4D6DC1ECAD5F91DFE8356D67E3FC7508
|texte= Botulinum toxin A injections improve apraxia of eyelid opening without overt blepharospasm associated with neurodegenerative diseases
}}
| This area was generated with Dilib version V0.6.23. |  |